TAP Blockade for Pain Control in One-Anastomosis Gastric Bypass

• Status: Unknown status
• Trial end date: 2019-04-30
• Target enrollment: 0
• Participant gender: All

Summary

Patients will be randomized into 2 groups:

• TAP: Patients undergoing TAP blockade, associated with intravenous Acetaminophen analgesia

• IV: Patients receiving only intravenous Acetaminophen analgesia

Postoperative pain 24 hours after surgery will be evaluated.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital General Universitario Elche

Criteria

Inclusion Criteria:

• Patients undergoing One-anastomosis gastric bypass (OAGB) as primary bariatric procedure

Exclusion Criteria:

• Patients undergoing OAGB as revisional procedure

• Patients undergoing other bariatric procedures

• Patients undergoing additional surgical procedures during the same surgical act (band removal, cholecystectomy, hernioplasty, or hiatal hernia treatment)

• Patients with history of allegy to local anesthetic drugs